Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michael J. Shield"'
Publikováno v:
Pharmacoepidemiology and Drug Safety. 11:393-400
Objectives To estimate the economic impact of misoprostol/diclofenac in a fixed combination tablet compared with diclofenac. Design Cohort study with a prospectively constructed, population-based, record-linkage database containing details of exposur
Autor:
John T. Dingle, Michael J. Shield
Publikováno v:
American Journal of Therapeutics. 3:195-203
Misoprostol, a prostaglandin E(1) analog, is currently available to manage ulcer disease, being used predominantly in the prophylaxis of nonsteroidal anti-inflammatory drug (NSAID)-induced ulceration, a serious side effect of anti-inflammatory therap
Publikováno v:
American Journal of Therapeutics. 2:595-599
Publikováno v:
American journal of therapeutics. 2(9)
Autor:
S. V. Morant, G. C. Robinson, Denis G. McDevitt, Michael J. Shield, F. E. Murray, Thomas M. MacDonald
Publikováno v:
Gastroenterology. 108:A156
Publikováno v:
Intensive Care Medicine. 5:171-181
The results from the bacteriological monitoring of 464 ITU patients are presented. The specimens analysed include urine, sputa, tracheostomy swabs, central venous pressure line catheter tips, blood cultures, wound drainage fluid, cerebro-spinal fluid
Autor:
Kingsley K. Amoako, Michael J. Shields, Noriko Goji, Chantal Paquet, Matthew C. Thomas, Timothy W. Janzen, Cesar I. Bin Kingombe, Arnold J. Kell, Kristen R. Hahn
Publikováno v:
Journal of Pathogens, Vol 2012 (2012)
Interest has recently been renewed in the possible use of Y. pestis, the causative agent of plague, as a biological weapon by terrorists. The vulnerability of food to intentional contamination coupled with reports of humans having acquired plague thr
Externí odkaz:
https://doaj.org/article/5fb92c552e804f51bf22b8db9329c6c5
Autor:
Michael J. Shield
Publikováno v:
British Journal of Surgery. 66:372-372
Autor:
Michael J. Shield
Publikováno v:
British Journal of Surgery. 66:372-372